Clinical Trial Update: PK Study of Dapagliflozin in Pediatric Subjects With T2DM [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluated dapagliflozin in pediatric subjects with Type 2 diabetes mellitus. The trial has completed, and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2016-11-21